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34 patients (55%).no patient died during the hospitalization, complications
(mainly arrhythmias) occurred in 19.6% of cases.
Conclusion: ACS in the young have specific epidemiological characteris-
tics. Cannabis users represent 22.9% of this population.
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Aims: Gender differences in management of patients with acute coronary
syndromes (ACS) have been reported. The aim of this study was to evaluate
the impact of gender on myocardial revascularization in patients with ACS
from a French nationwide registry (ONACI). 
Methods and Results: We analysed data from a nationwide French pro-
spective multicentre registry including 64,932 ACS patients (mean age
65.7±13.3; 27% women, 31% ST-elevation myocardial infarction (STEMI))
recruited in 99 centres between 2004 and 2008. Women were older than men
and had higher rates of cardiovascular risk factors. Women were more likely
to have normal vessel/non-significant coronary artery disease (<50% stenosis
in all epicardial vessels; 8.4% vs. 3.8%, p<0.001) and less likely to have left-
main and three vessel disease. After adjustment for age, risk factor, and extent
of disease, myocardial revascularization (defined as the use of percutaneous
coronary intervention (PCI) or coronary artery bypass grafting) was less fre-
quently used in women than in men (adjusted OR=0.83; 95% CI: 0.78-0.87).
For those receiving PCI, In-hospital mortality occurring within 24 hours of
intervention was higher in women (3.6% vs. 1.2%; adjusted OR=0.51; 95%
IC: 1.22-1.87).
Conclusion: In the present study, women with ACS were likely to have
cardiovascular disease risk factors, but were more likely to have normal
vessel/non-significant angiographic coronary artery disease. In patients with
advanced disease, myocardial revascularization seems to be less used in
women compared to men whatever the type of ACS. Further study regarding
long-term clinical outcomes according to sex and myocardial revascularization
is warranted.
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Aim: The real clinical impact of Optical Coherence Tomography (OCT) –
defined abnormalities remains unknown. We investigated prognostic impact of
tissue protrusion between stent struts after stent implantation in patients with
non-ST elevation acute coronary syndromes (NSTEACS).
Methods: Prospective study of consecutive NSTEACS pts (≤72 h) under-
going PCI for an infarct-related artery presenting a single lesion without dif-
fuse disease on the culprit artery. Pts were treated at the operator’s discretion.
OCT was performed after initial coronary angiogram and at end of angioplasty
procedure. Prolapse was defined as projection of tissue (plaque/thrombus) into
the lumen between stent struts after implantation. Primary endpoint of proce-
dural complications associated no reflow + PCI-related myocardial infarction
(MI) (20% rise in troponin over baseline at 24h). Secondary endpoint was
functional result of angioplasty assessed by fractional flow reserve (FFR)
measured at end of procedure. 
Results: 43 pts were included, mean age 63±11 ans, 90% men. Tissue pro-
trusion was observed in 35(81%), tissue took up a median 8.85% [IQR 6.2-
14.2%] of intra-luminal area over a median length of 2.8mm [IQR 1.4-5.2].
Presence of protrusion was not associated with cardiovascular risk factors or
pre-treatment with aspirin, thienopyridines, antiGP IIb/IIIa or anticoagulants.
Tissue protrusion had no impact on procedural complications or FFR (Table). 
Conclusion: Tissue protrusion through struts after stent implantation is fre-
quent on OCT in NSTEACS pts undergoing angioplasty. It occludes on
average 10% of in-stent area but does not limit flow or impact on post-proce-
dural complications.
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Background: Silent Atrial Fibrillation (AF) has recently been shown to be
common in acute myocardial infarction (AMI) and to dramatically increase in-
hospital death. However, the long term prognosis of silent AF in AMI remains
unknown. 
Methods: From the 1st May 2011 and the 31st January 2013 all the
consecutive patients were prospectively analyzed by continuous ECG moni-
toring (CEM) during the first 48 hours after admission for an AMI. Silent AF
was defined as asymptomatic episodes lasting at least 30 sec. Patients dis-
charged alive and with a follow-up at 1 year were included in the present
study. Patients who developed silent AF were compared with symptomatic AF
and No AF group.
Results: Among the 737 patients included, 96 (13.0%) developed silent AF
and 56 (7.6%) developed symptomatic AF during their hospital stay.
Compared with the no AF group, patients with silent AF were markedly older
80 (64-84) vs. 61 (53-75) years; p<0.001), more frequently women (42% vs.
30%); p=0.069), and less frequently smoker (24% vs. 37%; p<0.001).GRACE
risk score was significantly higher in silent AF group (131(101-148)) than in
no AF group (98(75-); p<0.001). They also had a significant left atrial (LA)
enlargement with LA surface indexed at 10.1 (8.5-12.6) vs. 9.2 (7.4-10.9)cm²/
m²; p<0.001 and LA volume indexed 29.4 (21.0-43.1) vs. 24.1 (18.1-32.9)
cm3/m²; p<0.001. At one year follow-up, rehospitalizations for heart failure
were more frequent after silent AF (4.2%) or symptomatic AF (8.9%) than in
no AF group (1.4%), (p<0.001). One year mortality was dramatically higher
in silent AF group (9.4%) and in symptomatic AF group (17.9%) than in no
AF group (3.8%) (p<0.001). 
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Abstract 0441 – Table
1st quartile 
[0-6.2%] 
2nd quartile 
[6.21-8.85%] 
3rd quartile 
[8.86-14.15%] 
4th quartile 
[14.16-31%] 
1st quartile 
[0-6.2%] 
No reflow 7.7% 22.2% 0 25% 0.33
Peri-procedural MI 6 (46%) 8 (80%) 6 (60%) 5 (50%) 0.39
FFR post-stenting 0.94±0.03 0.94±0.06 0.93±0.03 0.93±0.04 0.99
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Conclusion: Silent AF in AMI severely impairs long term prognosis,
including rehospitalization for heart failure and death. Our large prospective
study suggests that silent AF screening should be improved after AMI in order
to identify patients at high risk for long term events.
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Background: Use of opioids is recommended for pain relief in patients
presenting acute myocardial infarction (AMI) but may slow antiplatelet
absorption and diminish its effects which can lead to treatment failure in sus-
ceptible individuals.
Aim: The aim of this study was to assess the potential clinical impact of
pre-hospital morphine use in ST-elevation myocardial infarction (STEMI)
patients from a nationwide French registry.
Methods: We assessed in-hospital complications and one-year survival
according to pre-hospital morphine use in the French Registry of Acute ST-
elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2010,
including 4,169 patients with AMI at the end of 2010 in 213 centres (76% of
active centres in France); 2,438 patients had STEMI or left bundle branch
block (LBBB), of whom 453 (19%) received morphine during pre-hospital
management. 
Results: Patients receiving morphine in pre-hospital management were
younger, with a higher rate of men, a lower cardiovascular risk profile, and a
lower early GRACE score (136±31 vs. 145±35, p<0.001). In-hospital compli-
cations (non-fatal re-MI, stroke, stent thrombosis, bleeding and transfusion)
and one-year mortality were not significantly different between both strategies
after adjustment. Using Cox multivariate analysis, pre-hospital morphine use
was not associated with a worse one-year survival (HR=0.69; 95%CI: 0.35 to
1.37, p=0.38). After propensity score matching (417 patients per group), one-
year survival was also similar with both strategies.
Conclusion: Pre-hospital morphine use was not associated with an
increase of in-hospital complication and one-year mortality; and, could be
more used as recommended in the current guidelines.
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Background: The benefit of anticoagulants (AC) to prevent thrombotic
complications during percutaneous coronary intervention (PCI) is well estab-
lished. In acute coronary syndrome (ACS) patients previously treated with
enoxaparin, an additional bolus of AC is not recommended if the last injection
was realized within 8 h. In this setting, many interventional cardiologists use
unfractionated heparin (UFH) at the time of sheath insertion. 
Objectives: The aim of our study was to describe local current practices
for AC use during PCI in patients already treated with enoxaparin and
admitted for ACS and to assess the biological impact of UFH addition at the
beginning of the procedure. 
Methods: A standardized survey was sent to the interventional cardiologists
of the southwest of France to investigate their practice in terms of periprocedural
AC use. In 2 centers, ACS patients previously treated with subcutaneous injec-
tion of enoxaparin within 8 h and who received intravenous UFH at the time of
sheath insertion were prospectively included and their plasma anti-Xa activity
was assessed at the sheath insertion and 30 min after UFH bolus. In-hospital
bleeding and ischemic events were collected. The adequate therapeutic window
was defined by anti Xa activity (range 0.5 to 0.9 IU/mL). Results: Among the
41 interventional cardiologists who replied, a large majority (75,6%) considered
the addition of UFH in patients who received enoxaparin within 8 h as a valid
option. 47 ACS patients were enrolled. The dose of the bolus of UFH was
highly variable from 20 to 90 UI / kg. Anti-Xa activities were above 0.9 IU/mL
in 14,9% of patients at the sheath insertion and in 72,3% of patients 30 min after
UFH injection. 2 bleeding complications occurred, both in over-coagulated
patients. No ischemic events were reported. 
Conclusion: The use of UFH in patients who already received enoxaparin
may result in over-anticoagulation and lead to bleeding complications.
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Background: Prevalence and correlates of prolonged dual antiplatelet
therapy (DAPT) in stable coronary artery disease (CAD) are unknown. Our
aims were to assess the proportion of stable CAD patients under long-term
DAPT and the correlates of its prescription, and to analyze its impact on prog-
nosis.
Methods: Between 2010 and 2011, 3691 patients with stable CAD for at
least 1 year (median 4 years) were divided in 2 groups according to their anti-
platelet therapy regimen at inclusion: patients under DAPT were compared to
those under single antiplatelet therapy (SAPT).
Results: Altogether, 868 (24%) patients received DAPT. Factors associ-
ated with long-term DAPT were a time interval since the last coronary event
<3 years, more multivessel and peripheral disease, prior drug eluting stent
implantation and markers for a lower bleeding risk (younger patients, higher
body mass index). After propensity score matching, the rate of the composite
endpoint (death, myocardial infarction, stroke) at 2 years was similar between
patients with or without DAPT: 5.5% versus 5.7% (p=0.9). The rate of
bleeding was also similar between groups: 1% versus 0.7%, respectively
(p=0.6).
Conclusions: Our study shows that a high proportion of stable CAD
patients is under DAPT in modern practice. Several correlates of DAPT were
identified. Of note and even so no increase in bleeding was observed, our
results do not support the prescription of prolonged DAPT.
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Background: In exploratory research strategy of coronary disease ranked
first exercise stress test (EST). Beyond its positive predictive value repre-
sented by the repolarization triggered by stress, it provides additional prog-
nostic and diagnostic information which includes exercise capacity especially
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